Viewing Study NCT04610658


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
Study NCT ID: NCT04610658
Status: TERMINATED
Last Update Posted: 2024-04-02
First Post: 2020-10-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module